Medifast, Inc. (FRA:MDF)

Medifast Statistics

Total Valuation

Medifast has a market cap or net worth of EUR 93.06 million. The enterprise value is -39.84 million.

Market Cap	93.06M
Enterprise Value	-39.84M

Important Dates

The last earnings date was Tuesday, February 17, 2026.

Earnings Date	Feb 17, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	10.31M
Shares Outstanding	n/a
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	9.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.28
PB Ratio	0.55
P/TBV Ratio	0.55
P/FCF Ratio	87.48
P/OCF Ratio	15.92
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	2.51
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.45

Financial Position

The company has a current ratio of 4.69, with a Debt / Equity ratio of 0.05.

Current Ratio	4.69
Quick Ratio	3.89
Debt / Equity	0.05
Debt / EBITDA	2.17
Debt / FCF	8.56
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -9.13% and return on invested capital (ROIC) is -29.67%.

Return on Equity (ROE)	-9.13%
Return on Assets (ROA)	-3.34%
Return on Invested Capital (ROIC)	-29.67%
Return on Capital Employed (ROCE)	-6.93%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	864,673
Profits Per Employee	-41,850
Employee Count	380
Asset Turnover	1.45
Inventory Turnover	3.53

Taxes

In the past 12 months, Medifast has paid 11.10 million in taxes.

Income Tax	11.10M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.01% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-40.01%
50-Day Moving Average	9.07
200-Day Moving Average	10.44
Relative Strength Index (RSI)	41.77
Average Volume (20 Days)	5

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	7.71

Income Statement

In the last 12 months, Medifast had revenue of EUR 328.58 million and -15.90 million in losses. Loss per share was -1.45.

Revenue	328.58M
Gross Profit	234.38M
Operating Income	-12.11M
Pretax Income	-4.80M
Net Income	-15.90M
EBITDA	24,699
EBIT	-12.11M
Loss Per Share	-1.45

Balance Sheet

The company has 142.47 million in cash and 9.11 million in debt, with a net cash position of 133.36 million.

Cash & Cash Equivalents	142.47M
Total Debt	9.11M
Net Cash	133.36M
Net Cash Per Share	n/a
Equity (Book Value)	169.42M
Book Value Per Share	16.43
Working Capital	135.18M

Cash Flow

In the last 12 months, operating cash flow was 5.85 million and capital expenditures -4.78 million, giving a free cash flow of 1.06 million.

Operating Cash Flow	5.85M
Capital Expenditures	-4.78M
Free Cash Flow	1.06M
FCF Per Share	n/a

Margins

Gross margin is 71.33%, with operating and profit margins of -3.68% and -4.84%.

Gross Margin	71.33%
Operating Margin	-3.68%
Pretax Margin	-1.46%
Profit Margin	-4.84%
EBITDA Margin	0.01%
EBIT Margin	-3.68%
FCF Margin	0.32%

Dividends & Yields

Medifast does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.16%
Shareholder Yield	-0.16%
Earnings Yield	-17.09%
FCF Yield	1.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medifast has an Altman Z-Score of 4.75 and a Piotroski F-Score of 3.

Altman Z-Score	4.75
Piotroski F-Score	3